• EAACI
  • Events
  • Professionals
  • Patients
  • News
Become a Member
Become a Member

EAACI Congress 2025 Back

13 - 16 June 2025 Glasgow, United Kingdom

Antonella Cianferoni

United States of America

Antonella Cianferoni

Antonella Cianferoni, MD, PhD, is an associate professor in pediatrics at the Perelman School of Medicine, University of Pennsylvania, and the medical director of the Food Allergy Immunotherapy program at the Children’s Hospital of Philadelphia (CHOP).

Sessions

Friday 13 Jun
15:15 - 15:45 Management of Eosinophilic Esophagitis as a side effect of food oral immunotherapy
17:45 - 19:15
IWS5 Exploring the clinical management of Eosinophilic Esophagitis Interactive Workshop Forth , Forth
Saturday 14 Jun
17:45 - 19:15
FT12 Early-life influences on allergy and immune development Flash Talks Dochart 1
Sunday 15 Jun
10:24 - 10:36 Dupilumab Is Efficacious in Children Aged 1–11 Years Weighing ≥15 kg With Eosinophilic Esophagitis Irrespective of Individual Atopic Comorbidities: 16-Week Results From the Phase 3 EoE KIDS Study

D3.403 Dupilumab improves multiple histopathologic features of eosinophilic esophagitis over 52 weeks: Post hoc analysis of the phase 3 LIBERTY EoE TREET study
×